Header01-REBRAND_MENARINISILICONBIOSYSTEMS

 

Press Releases

11/30/2021

New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care


As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where its CELLSEARCH® technology can enumerate Circulating Multiple Myeloma Cells (CMMCs) for non-invasive monitoring of disease

continue →

Topics: CELLSEARCH, Liquid biopsy, Multiple myeloma, CLIA Lab, LDT

03/31/2021

Menarini Silicon Biosystems launches CELLSEARCH® Circulating Multiple Myeloma Cells Assay, a new non-invasive test to monitor disease status in clinical research studies


The new test, available as a Lab Service throughout Europe and US, leverages the Gold Standard CELLSEARCH platform to enumerate Circulating Multiple Myeloma Cells from blood and offers real-time standardized monitoring of multiple myeloma in clinical research studies.

continue →

Topics: CELLSEARCH, Multiple myeloma, CMMCs, Lab Services

08/4/2020

Two Studies Presented at AACR Meeting Deepen Understanding Of Cancer Mechanisms

Researchers Use Menarini’s Liquid Biopsy Technology to Find Genetic Alterations in Cancer Cells that May Improve Prognosis and Treatment

continue →

Topics: CELLSEARCH, metastatic breast cancer, Multiple myeloma, HER2, AACR

03/12/2019

Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression

continue →

Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs

11/27/2018

Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting

DEPArray Technology Used for Detection and Isolation of Lymphoma and Multiple Myeloma Cells

continue →

Topics: single-cell isolation, deparray, copy number alteration, Multiple myeloma, classical Hodgkin Lymphoma, Reed-Sternberg (HRS) Cells